Biomimetic reactive oxygen/nitrogen nanoscavengers inhibit “ferroptosis storm” and modulate immune targeting for acute kidney injury

IF 11.5 1区 医学 Q1 CHEMISTRY, MULTIDISCIPLINARY Journal of Controlled Release Pub Date : 2025-03-10 Epub Date: 2025-01-08 DOI:10.1016/j.jconrel.2025.01.006
Yuxin Cao , Xiaowei Liu , Chunjing Guo , Weili Yang , Xuemei Wang , Xinxin Wang , Haiyu Xu , Wenming Wang , Dandan Liu , Jingwen Zhang , Wenhao Cui , Yuxiu Chen , Xuan Guo , Daquan Chen
{"title":"Biomimetic reactive oxygen/nitrogen nanoscavengers inhibit “ferroptosis storm” and modulate immune targeting for acute kidney injury","authors":"Yuxin Cao ,&nbsp;Xiaowei Liu ,&nbsp;Chunjing Guo ,&nbsp;Weili Yang ,&nbsp;Xuemei Wang ,&nbsp;Xinxin Wang ,&nbsp;Haiyu Xu ,&nbsp;Wenming Wang ,&nbsp;Dandan Liu ,&nbsp;Jingwen Zhang ,&nbsp;Wenhao Cui ,&nbsp;Yuxiu Chen ,&nbsp;Xuan Guo ,&nbsp;Daquan Chen","doi":"10.1016/j.jconrel.2025.01.006","DOIUrl":null,"url":null,"abstract":"<div><div>Cisplatin (Cis), a potent chemotherapeutic agent, often causes acute kidney injury (AKI), limiting its clinical efficacy. RONS flares at the AKI site are a key factor in its progression. In this study, leveraging the advantages of cell membrane-coated biomimetic nanocarriers, we developed a multifunctional biomimetic nanodelivery system nano-RONS-sacrificial agent for AKI treatment. Ferrostatin-1 (Fer-1) was conjugated with curcumin (Cur) via 4-carboxyphenylboronic acid (4-PBA) and fucoidan (Fuc) to construct a ROS-responsive nanodelivery system (FPPF@Cur), which was further coated with M2 macrophage membranes (M2M) to form the multifunctional biomimetic nano-RONS-sacrificial agent (M2FPPF@Cur) designed for targeted delivery of Cur to injured kidneys. M2FPPF@Cur demonstrated rapid accumulation in the injured kidneys with selective uptake and prolonged retention in injured kidneys, the ROS-responsive mechanism facilitated controlled drug release at the AKI site, reducing off-target effects and enhancing therapeutic efficacy, effectively scavenging RONS, reducing lipid peroxidation, and targeting GPX4 protein to inhibit “ferroptosis storm”. It suppressed the expression of inflammation-related NF-κB/NLRP3 signaling pathway proteins and regulated the repolarization of macrophages from M1 to M2 phenotype to regulate inflammation. The results showed that injected M2FPPF@Cur specifically accumulated in the injured kidney and exerted good renoprotective effects ultimately preventing the progression of AKI.</div></div>","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"379 ","pages":"Pages 59-76"},"PeriodicalIF":11.5000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168365925000082","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Cisplatin (Cis), a potent chemotherapeutic agent, often causes acute kidney injury (AKI), limiting its clinical efficacy. RONS flares at the AKI site are a key factor in its progression. In this study, leveraging the advantages of cell membrane-coated biomimetic nanocarriers, we developed a multifunctional biomimetic nanodelivery system nano-RONS-sacrificial agent for AKI treatment. Ferrostatin-1 (Fer-1) was conjugated with curcumin (Cur) via 4-carboxyphenylboronic acid (4-PBA) and fucoidan (Fuc) to construct a ROS-responsive nanodelivery system (FPPF@Cur), which was further coated with M2 macrophage membranes (M2M) to form the multifunctional biomimetic nano-RONS-sacrificial agent (M2FPPF@Cur) designed for targeted delivery of Cur to injured kidneys. M2FPPF@Cur demonstrated rapid accumulation in the injured kidneys with selective uptake and prolonged retention in injured kidneys, the ROS-responsive mechanism facilitated controlled drug release at the AKI site, reducing off-target effects and enhancing therapeutic efficacy, effectively scavenging RONS, reducing lipid peroxidation, and targeting GPX4 protein to inhibit “ferroptosis storm”. It suppressed the expression of inflammation-related NF-κB/NLRP3 signaling pathway proteins and regulated the repolarization of macrophages from M1 to M2 phenotype to regulate inflammation. The results showed that injected M2FPPF@Cur specifically accumulated in the injured kidney and exerted good renoprotective effects ultimately preventing the progression of AKI.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
仿生活性氧/氮纳米清除剂抑制“铁中毒风暴”并调节急性肾损伤的免疫靶向。
顺铂是一种强效的化疗药物,常引起急性肾损伤,限制了其临床疗效。在AKI地点的RONS耀斑是其进展的关键因素。在本研究中,利用细胞膜包覆仿生纳米载体的优势,我们开发了一种多功能仿生纳米递送系统-纳米rons -牺牲剂治疗AKI。通过4-羧基苯基硼酸(4-PBA)和褐藻聚糖(Fuc)将他丁铁素-1 (ferr -1)与姜黄素(Cur)偶联,构建ros响应的纳米递送系统(FPPF@Cur),并进一步包被M2巨噬细胞膜(M2M),形成多功能仿生纳米ros牺牲剂(M2FPPF@Cur),设计用于将Cur靶向递送到受损肾脏。M2FPPF@Cur在损伤肾脏中快速积累,选择性摄取,在损伤肾脏中长时间滞留,ros反应机制促进AKI部位药物的控制释放,减少脱靶效应,提高疗效,有效清除RONS,减少脂质过氧化,靶向GPX4蛋白抑制“铁下沉风暴”。抑制炎症相关NF-κB/NLRP3信号通路蛋白的表达,调节巨噬细胞从M1向M2表型的复极化,调节炎症。结果表明,注射M2FPPF@Cur在损伤肾脏特异性积累,并发挥良好的肾保护作用,最终阻止AKI的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Controlled Release
Journal of Controlled Release 医学-化学综合
CiteScore
18.50
自引率
5.60%
发文量
700
审稿时长
39 days
期刊介绍: The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.
期刊最新文献
Electric fields to enhance drug delivery to non-superficial tumors Caspase-1-targeting siRNA nanoparticles suppress pyroptosis to prevent force-induced root resorption Harnessing the power of microbiome, nanotechnology, and immunity against cancer Poly(2-oxazoline) and poly(2-oxazine)-based nanomedicines: Advancements, opportunities and challenges Fine-tuned phenylboronic acid polymer assembly with tannic acid enables adeno-associated virus to evade and suppress neutralizing antibody responses
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1